Parkinson’s
Researchers have directly seen and measured the protein clusters thought to spark Parkinson’s disease for the first time, marking a major milestone in understanding the condition. These microscopic clusters, known as alpha-synuclein oligomers, have long been suspected as the starting point for Parkinson’s but had remained undetectable in human brain tissue until now. A team [...]
A woman with Parkinson’s disease played the clarinet during brain surgery, allowing doctors to observe immediate improvements in her movement. Denise Bacon, 65, from Crowborough in East Sussex, underwent Deep Brain Stimulation (DBS) at King’s College Hospital while awake. Her playing helped surgeons assess the success of the procedure in real time. DBS involves implanting [...]
NR Times explores the latest business and pharmaceutical developments in the world of neurorehabilitation. New partnership to distribute of MedRhythms devices for stroke and Parkinson’s Neurorehabilitation company MedRhythms has entered a strategic partnership with Edwards Health Care Services (EHCS), a leading provider of direct-to-home medical products. The partnership enables nationwide distribution of MedRhythms' currently available [...]
People with Parkinson’s are receiving a new investigational treatment after a successful study demonstrated the therapy’s safety in non-human primates and refined the method for its delivery. Biotechnology company Aspen Neuroscience said it would enrol a third group of participants in its ASPIRO trial after the first four patients safely tolerated the therapy. The Phase [...]
Emerging research is exploring the potential of photobiomodulation (PBM) - a light-based therapy targeting the gut-brain axis- as a promising new treatment for Parkinson’s disease. A recently published clinical trial, conducted on 60 participants in Canada, reported clinically significant improvements in multiple Parkinson’s symptoms following treatment with photobiomodulation (PBM) therapy. The results, presented last month at [...]
Martial arts classes are transforming the lives of people living with neurological conditions such as multiple sclerosis (MS) and Parkinson’s disease. NR Times editor Stephanie Price speaks to Adam Poulter, founder of Foundation Physio, to find out more. Neurophysiotherapy service Foundation Physio is helping its clients to build strength, flexibility and co-ordination through a ten-week [...]
NR Times explores the latest research developments in the world of neurology and neurorehabilitation. Scientists reverse Alzheimer’s in mice using nanoparticles Researchers have demonstrated a nanotechnology strategy that reverses Alzheimer’s disease in mice. Unlike traditional nanomedicine, which relies on nanoparticles as carriers for therapeutic molecules, this approach employs nanoparticles that are bioactive in their own [...]
Scientists have identified an enzyme that protects brain cells from Parkinson's disease by regulating how mitochondria — the cell’s energy producers — are recycled and replaced. The protein complex, known as PP2A-B55α, acts as a molecular switch that determines whether cells repair or create mitochondria, maintaining the energy balance vital for neuron survival. Mitochondria are [...]
People with restless leg syndrome may be up to 60 per cent more likely to develop Parkinson's disease, new research suggests. The condition, which affects up to 10 per cent of the population and is more common in women, causes an unpleasant crawling sensation in the legs, usually at night, and an almost irresistible urge [...]
Deep brain stimulation has been shown to ease symptoms and improve quality of life for people with Parkinson's, with benefits lasting five years, a major US study has found. The trial, conducted across 23 movement disorder centres, was the largest prospective long-term study of deep brain stimulation (DBS) for Parkinson's disease. Nearly 200 patients received [...]
